Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AUX 001

Next Previous
X
Search
Drug Profile

AUX 001

Alternative Names: AUX-001; Nicorandil extended-release

Latest Information Update: 28 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Auxilius Pharma
  • Class Ischaemic heart disorder therapies; Nitrates; Small molecules; Vasodilators
  • Mechanism of Action Guanylate cyclase stimulants; KATP channel stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Angina pectoris

Most Recent Events

  • 30 Aug 2024 Updated adverse events and pharmacokinetics data from the phase I trial in Angina pectoris presented at the ESC Congress 2024 - Annual Congress of the European Society of Cardiology (ESC-Card-2024)
  • 23 Feb 2024 Auxilius Pharma plans to launch AUX 001 for the treatment of Angina pectoris in the US by 2027
  • 23 Feb 2024 Auxilius Pharma plans a phase III trial for Angina pectoris in 2025

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top